 |
|
|
| |
EFFECTIVENESS OF ELBASVIR/GRAZOPREVIR IN PATIENTS WITH HEPATITIS C VIRUS GENOTYPE 1 INFECTION WHO RECEIVE OPIOID AGONIST THERAPY: TREATMENT UTILIZATION AND THE IMPACT OF CONCOMITANT PSYCHIATRIC MEDICATIONS
|
| |
| |
Reported by Jules Levin
EASL 2019 April 10-14 Vienna
JR Kramer1,2, A Puenpatom3, Y Cao1, H El-Serag1,2, F Kanwal1,2
1Center for Innovations in Quality, Effectiveness and Safety (IQuESt), Michael E. DeBakey VA Medical Center, Houston, TX, USA
2Department of Medicine, Baylor College of Medicine, Houston, TX, USA
3Merck & Co., Inc., Kenilworth, NJ, USA
|
| |
|
|
|
|
|
